UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

  

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 22, 2020

 

AMPLITUDE HEALTHCARE ACQUISITION
CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-39138   84-2984849
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1177 Avenue of the Americas, FL 40
New York, New York

  10036
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 823-1900

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading
Symbol(s)

  Name of each exchange on
which registered
         
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant   AMHCU   The NASDAQ Stock Market LLC
         
Class A Common Stock, par value $0.0001 per share   AMHC   The NASDAQ Stock Market LLC
         
Warrants, each whole warrant exercisable for one share of Class A Common Stock for $11.50 per share   AMHCW   The NASDAQ Stock Market LLC

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

  

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On December 22, 2020, Amplitude Healthcare Acquisition Corporation (the “Company”) held its 2020 annual meeting of stockholders (the “Meeting”). At the Meeting, stockholders (i) re-elected two directors to serve as the Class I directors on the Company’s board of directors (“Board”) until the 2023 annual meeting of stockholders or until their successors are duly elected and qualified and (ii) ratified the selection by the audit committee of the Board of WithumSmith+Brown, PC (“Withum”) to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2020.

 

Set forth below are the final voting results for each of the proposals:

 

Proposal No. 1 – Election of directors

 

 Peter Dolan and Glenn Reicin were re-elected to serve as the Class I directors. The voting results were as follows:

 

  For   Against   Abstain   Broker Non-Votes
Peter Dolan 2,500,000   0   0   N/A
Glenn Reicin 2,500,000   0   0   N/A

 

Proposal No. 2 – Ratification of independent registered public accounting firm

 

The stockholders ratified the selection of Withum to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2020. The voting results were as follows:

 

For   Against   Abstain   Broker Non-Votes
9,132,167   0   151   N/A

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 29, 2020

 

  AMPLITUDE HEALTHCARE ACQUISITION CORPORATION
     
  By: /s/ Bala Venkataraman
  Name:  Bala Venkataraman
  Title: Chief Executive Officer

 

 

2